Hepatitis Be Virus Antibody
Also known as: HBEAB
Use
Hepatitis Be Virus Antibody testing is used to monitor HBV therapy. It should be ordered along with HBV DNA, HBV surface antigen, HBV surface antibody, and HBe antigen. The presence of anti-HBe typically indicates resolution of hepatitis B infection, although it can be detected in a small proportion of chronic HBV infections. This antibody can be indicative of recent or resolved infection and provides important clinical information in conjunction with other hepatitis B markers.
Special Instructions
Not provided.
Limitations
The assay should not be utilized for blood donor screening, reentry protocols, or screening of human cells, tissues, and cellular- and tissue-based products (HCT/P). Grossly hemolyzed, icteric, lipemic, or particulate-containing specimens may lead to test rejection. Repeated freeze/thaw cycles should be avoided to ensure specimen integrity. The presence of anti-HBe is reactive and consistent with recent or remote hepatitis B infection. However, this marker alone cannot differentiate active infection from resolved infection without additional HBV markers.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
Hepatitis Be Antibody
Protein
LOINC Codes
- 13953-5 - HBV e Ab SerPl Ql IA
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube or serum separator tube (SST)
Collection Instructions
Separate serum or plasma from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated.
Causes for Rejection
Specimens that are heat-inactivated, grossly hemolyzed, grossly icteric, grossly lipemic, or contain particulate material.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant